Showing results (111-120 of 205) with videos related to

Sort By:
Pageof 21
Experimental Physiology|July 1, 2026
Impairments in mitochondrial dynamics and morphology in skeletal muscle of breast cancer patients after a single paclitaxel administrationJoris Mallard, Elyse Hucteau, Laura Somme, et al.
Anti-Cancer Drugs|December 25, 2009
Intraoperative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I studyEmmanuel Guardiola, Bruno Chauffert, Delphine Delroeux, et al.
Cancer Research|January 25, 2011
Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cellsRomain Bedel, Antoine Thiery-Vuillemin, Camille Grandclement, et al.
Breast (Edinburgh, Scotland)|July 23, 2014
A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trialAntonio Llombart-Cussac, Xavier Pivot, Laura Biganzoli, et al.
American Journal of Physiology. Cell Physiology|September 12, 2022
Development of skeletal muscle atrophy and intermuscular adipose tissue in patients with early breast cancer treated with chemotherapyJoris Mallard, Elyse Hucteau, Laura Bender, et al.
Bulletin Du Cancer|December 15, 2015
[Perception of pT1a,b pN0 breast tumor prognosis by the French oncology community: Results of the EURISTIC national survey]Marc Spielmann, Florence Dalenc, Yoann Pointreau, et al.
Bulletin Du Cancer|May 30, 2015
[Efficacy, safety and cost of eribulin in patients with metastatic breast cancer]Marie-Justine Paillard, Elsa Curtit, Erion Dobi, et al.
Cancer|September 24, 2004
Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?Emmanuel Guardiola, Xavier Pivot, Olivier Dassonville, et al.
Breast Cancer Research and Treatment|May 8, 2013
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancerHope S Rugo, Mario Campone, Dino Amadori, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2020
Anti-MUC1-C Antibody-Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation TherapyAlexandre Detappe, Clélia Mathieu, Caining Jin, et al.
Pageof 21